Sarepta, Replimmune, Capricor rise as FDA’s biologics head departs

22 hours ago 1
US Food and Drug Administration (FDA)

Sarepta Therapeutics (NASDAQ:SRPT), Replimune (NASDAQ:REPL), and Capricor Therapeutics (NASDAQ:CAPR), which faced regulatory setbacks from the FDA’s biologics division, recently witnessed sharp increases in their share prices on Tuesday after the head of that division, Vinay

Recommended For You

More Trending News

Read Entire Article
  1. Homepage
  2. Finance
  3. Sarepta, Replimmune, Capricor rise as FDA’s biologics head departs

Related

Gildan Activewear declares $0.226 dividend

Gildan Activewear declares $0.226 dividend

9 minutes ago 0
Masco declares $0.31 dividend

Masco declares $0.31 dividend

13 minutes ago 0
Accenture invests in YearOne

Accenture invests in YearOne

14 minutes ago 0
Mastercard in Charts: Worldwide GDV and Transactions up over 9% Y/Y, Cross-border volume jumps 19%

Mastercard in Charts: Worldwide GDV and Transactions up over...

15 minutes ago 0
Employment cost growth holds steady in Q2, beats expectations

Employment cost growth holds steady in Q2, beats expectation...

15 minutes ago 0
Vivakor declares $3.50 dividend

Vivakor declares $3.50 dividend

20 minutes ago 0
Eicher Motors Q1 Results: Net profit rises 9% to Rs 1,205 crore, revenue up 15%

Eicher Motors Q1 Results: Net profit rises 9% to Rs 1,205 cr...

22 minutes ago 0
ITR Filing Season 2025: How many times can you revise your income tax return? Check inside

ITR Filing Season 2025: How many times can you revise your i...

29 minutes ago 0
easyMarkets and Real Madrid CF reaffirm partnership; exciting initiatives, including flagship campaign, lie ahead  

easyMarkets and Real Madrid CF reaffirm partnership; excitin...

35 minutes ago 0
Indonesia bets a new sovereign wealth fund will finally unlock its potential

Indonesia bets a new sovereign wealth fund will finally unlo...

54 minutes ago 0
India engaged in negotiations with US over tariffs, will take all steps to protect national interest: Piyush Goyal

India engaged in negotiations with US over tariffs, will tak...

55 minutes ago 0
Peabody Energy declares $0.075 dividend

Peabody Energy declares $0.075 dividend

59 minutes ago 0
Comcast declares $0.33 dividend

Comcast declares $0.33 dividend

59 minutes ago 0
HONEST Act: Should members of Congress be allowed to trade stocks?

HONEST Act: Should members of Congress be allowed to trade s...

1 hour ago 0
SNDL stock jumps as income turns positive for the first time

SNDL stock jumps as income turns positive for the first time...

1 hour ago 0
MPLX to buy Northwind Midstream in $2.375B deal

MPLX to buy Northwind Midstream in $2.375B deal

1 hour ago 0
Trump fumes at Powell for not cutting rates, again

Trump fumes at Powell for not cutting rates, again

1 hour ago 0
ATI and Boeing extend and expand titanium supply long-term agreement

ATI and Boeing extend and expand titanium supply long-term a...

1 hour ago 0
AbbVie Non-GAAP EPS of $2.97 beats by $0.06, revenue of $15.42B beats by $390M

AbbVie Non-GAAP EPS of $2.97 beats by $0.06, revenue of $15....

1 hour ago 0
As Figma goes public, a turning point in the long-awaited IPO market recovery takes shape

As Figma goes public, a turning point in the long-awaited IP...

1 hour ago 0

Trending

1. ceo west bengal
2. allahabad university
3. mitchell santner
4. viktor gyökeres
5. most runs in a test series
6. google pay
7. india vs pakistan
8. joan garcía
9. ladki bahin yojana
10. arsenal

Popular

صدور هشدار زرد هواشناسی در چهارمحال و بختیاری

صدور هشدار زرد هواشناسی در چهارمحال و بختیاری

2 days ago 3
تحمیل قحطی و گرسنگی بر مردم غزه، فاجعه انسانی است

تحمیل قحطی و گرسنگی بر مردم غزه، فاجعه انسانی است

1 week ago 3
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© FBT Company 2025. All rights are reserved